Margarita A. Migunova

Margarita A. Migunova

Auto-generated profile, based on publicly available information

Margarita A. Migunova

Institute of Cytology Russian Academy of Science

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2026 in Human Cell
Verified
Journal Article
Closed access
PDF file
DSD. V. Smirnova
D. V. Smirnova
PKPolina Kuchur
Polina Kuchur
DSD. A. Serdiukova
D. A. Serdiukova
VNV. A. Nyrov
V. A. Nyrov
ABA. Babakovskaya
A. Babakovskaya
Anna MalashichevaAnna Malashicheva
Anna Malashicheva

31 October 2026 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
ABAnna A. Belyaeva
Anna A. Belyaeva
ABAlyona Babakovskaya
Alyona Babakovskaya
GMGeorgy P. Maslakov
Georgy P. Maslakov
MMMargarita A. Migunova
Margarita A. Migunova
NBNadezhda V. Boyarskaya
Nadezhda V. Boyarskaya
АМАнна Борисовна Малашичева
Анна Борисовна Малашичева
Highlights Endothelium derived from induced pluripotent stem cells enhances osteoblast mineralization in the same way as primary endothelium, i.e. it is suitable as a functional model. The endothelium of a patient with a syndromic form of pathological calcification (Singleton–Merten syndrome) retains this ability, and the introduction of the mutant variant DDX58 into the endothelium weakens it. Macrophages, regardless of polarization, completely remove endothelium-dependent mineralization. The outcome of osteogenic differentiation is determined not by a single cell type, but by the complex composition of the cellular community. Aim. To determine how endothelial cells and macrophages influence osteogenic differentiation of cells targeted in pathological calcification, and whether this balance is altered by a DDX58 mutation causing Singleton–Merten syndrome (SMS), a monogenic form of vascular and valvular calcification. Methods. Endothelial cells were derived from induced pluripotent stem cells (iPSCs) of a patient with SMS and from a control line. Osteoblasts, smooth muscle cells and aortic valve interstitial cells were cultured in osteogenic medium alone and in direct co-culture with endothelium: iPSC-derived, primary (HUVEC), and primary transduced with wild-type or mutant DDX58. In part of the experiments, macrophages derived from the THP-1 line (unpolarised M0 or pro-inflammatory M1) were added to the co-culture. The endothelial phenotype of the derived cells was confirmed by immunocytochemistry for CD31 and von Willebrand factor. Mineralisation was assessed by alizarin red staining followed by dye extraction. Results. Endothelium was the strongest stimulator of mineralisation: in its presence osteoblasts mineralised the matrix about twelve-fold more intensely than in osteogenic medium alone. iPSC-derived endothelium acted identically to primary endothelium, including the patient-derived line. Introducing mutant DDX58 into primary endothelium weakened its stimulatory action, whereas the wild-type variant changed nothing; the DDX58 genotype of macrophages had no effect. Adding macrophages abolished the endothelial effect entirely – equally for M0 and M1 and in every combination with transduced endothelium – while macrophages alone did not induce osteogenic differentiation. In co-cultures with smooth muscle cells and valve interstitial cells endothelium also enhanced mineralisation, with no differences between DDX58 variants. Conclusion. Endothelium provides a permissive signal for osteogenic differentiation, macrophages block this signal, and the DDX58 mutation acts from the endothelial rather than the mesenchymal side. Therapies aimed at slowing pathological calcification should target intercellular communication rather than a single cell type.